Management of Variceal Hemorrhage

Continue Vasoactive Drug Therapy

The American Association for the Study of Liver Diseases recommends continuing IV octreotide for 3-5 days after endoscopic band ligation to reduce the risk of early rebleeding, with a standard regimen of continuous IV infusion of 50 µg/h 1
The combination of vasoactive drugs plus endoscopic therapy is more effective than either alone because it combines local hemostatic effects with sustained portal pressure reduction 1
Stopping octreotide prematurely increases the risk of early rebleeding, which occurs in approximately 15% of cases within the first few days 1

The American Association for the Study of Liver Diseases recommends continuing ceftriaxone 1 g IV daily for up to 7 days total to reduce bacterial infections and improve survival 1, 2
Antibiotic prophylaxis reduces bacterial infections, decreases early rebleeding rates, and improves survival 2, 6
Ceftriaxone is superior to norfloxacin in patients with advanced cirrhosis and covers approximately 95% of flora commonly isolated in cirrhotic patients 5

The American Association for the Study of Liver Diseases recommends maintaining a restrictive transfusion strategy with a hemoglobin target of 7-9 g/dL to avoid increasing portal pressure 1
Monitor for and manage hepatic encephalopathy with lactulose if it develops 3
Avoid nephrotoxic drugs, large volume paracentesis, and beta-blockers during the acute bleeding episode 3

The American Association for the Study of Liver Diseases recommends assessing if the patient meets high-risk criteria that would warrant early pre-emptive TIPS within 72 hours, including Child-Pugh C with score <14 or Child-Pugh B >7 with active bleeding at endoscopy despite vasoactive agents 3
Early pre-emptive TIPS in high-risk patients significantly improves survival compared to standard therapy 2

The American Association for the Study of Liver Diseases recommends initiating planning for secondary prophylaxis to prevent rebleeding, which has a 60% risk within 1-2 years if untreated, with a combination of non-selective beta-blockers and repeat endoscopic band ligation 8, 7
Beta-blockers should be started once the patient is hemodynamically stable and no longer at risk for acute bleeding 3

The American Association for the Study of Liver Diseases recommends performing surveillance endoscopy at 1-3 months, then every 3-6 months to check for variceal recurrence 6, 8, 7
Varices recur in a significant proportion of patients after obliteration 8, 7

Do not stop octreotide immediately after successful endoscopy, as this increases early rebleeding risk 4
Do not use broader-spectrum antibiotics like piperacillin-tazobactam without indication, as ceftriaxone provides adequate coverage and reduces resistance concerns 5
Do not start beta-blockers during the acute bleeding episode, but wait until hemodynamic stability is achieved and the patient is ready for discharge 3

If bleeding recurs or cannot be controlled despite combined pharmacological and endoscopic therapy, urgent rescue TIPS is indicated 2, 3
Balloon tamponade can serve as a temporary bridge while arranging for TIPS 7, 2
Persistent bleeding despite optimal therapy occurs in 10-20% of cases and requires escalation to TIPS 2